| http://www.w3.org/ns/prov#value | - 4/2011 INDICATIONS AND USAGE LYSTEDA (tranexamic acid) Tablets is an antifibrinolytic indicated for the treatment of cyclic heavy menstrual bleeding. (1) DOSAGE AND ADMINISTRATION 1,300 mg (two 650 mg tablets) three times a day (3,900 mg/day) for a maximum of 5 days during monthly menstruation (2.1) Renal impairment: Dosage adjustment is needed if serum creatinine concentration (Cr) is higher than
|
